These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways. Danpure CJ Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096 [TBL] [Abstract][Full Text] [Related]
23. Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications. Oppici E; Fodor K; Paiardini A; Williams C; Voltattorni CB; Wilmanns M; Cellini B Proteins; 2013 Aug; 81(8):1457-65. PubMed ID: 23589421 [TBL] [Abstract][Full Text] [Related]
24. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1. Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008 [TBL] [Abstract][Full Text] [Related]
25. Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli. Cellini B; Montioli R; Bianconi S; López-Alonso JP; Voltattorni CB Protein Pept Lett; 2008; 15(2):153-9. PubMed ID: 18289107 [TBL] [Abstract][Full Text] [Related]
26. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele. Fargue S; Lewin J; Rumsby G; Danpure CJ J Biol Chem; 2013 Jan; 288(4):2475-84. PubMed ID: 23229545 [TBL] [Abstract][Full Text] [Related]
27. Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1. Fargue S; Rumsby G; Danpure CJ Biochim Biophys Acta; 2013 Oct; 1832(10):1776-83. PubMed ID: 23597595 [TBL] [Abstract][Full Text] [Related]
28. Immunocytochemical localization of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type 1. Cooper PJ; Danpure CJ; Wise PJ; Guttridge KM J Histochem Cytochem; 1988 Oct; 36(10):1285-94. PubMed ID: 3418107 [TBL] [Abstract][Full Text] [Related]
29. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation. Danpure CJ; Purdue PE; Fryer P; Griffiths S; Allsop J; Lumb MJ; Guttridge KM; Jennings PR; Scheinman JI; Mauer SM Am J Hum Genet; 1993 Aug; 53(2):417-32. PubMed ID: 8101040 [TBL] [Abstract][Full Text] [Related]
30. Oxalate synthesis in mammals: properties and subcellular distribution of serine:pyruvate/alanine:glyoxylate aminotransferase in the liver. Ichiyama A; Xue HH; Oda T; Uchida C; Sugiyama T; Maeda-Nakai E; Sato K; Nagai E; Watanabe S; Takayama T Mol Urol; 2000; 4(4):333-40. PubMed ID: 11156700 [TBL] [Abstract][Full Text] [Related]
31. Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis. Bertoldi M; Cellini B; Paiardini A; Montioli R; Borri Voltattorni C Biochim Biophys Acta; 2008 Sep; 1784(9):1356-62. PubMed ID: 18492492 [TBL] [Abstract][Full Text] [Related]
32. Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease. Danpure CJ; Lumb MJ; Birdsey GM; Zhang X Biochim Biophys Acta; 2003 Apr; 1647(1-2):70-5. PubMed ID: 12686111 [TBL] [Abstract][Full Text] [Related]
33. Electrostatic interactions drive native-like aggregation of human alanine:glyoxylate aminostransferase. Dindo M; Conter C; Cellini B FEBS J; 2017 Nov; 284(21):3739-3764. PubMed ID: 28906061 [TBL] [Abstract][Full Text] [Related]
34. Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1. Gatticchi L; Dindo M; Pampalone G; Conter C; Cellini B; Takayama T Biochem Biophys Res Commun; 2023 Feb; 645():118-123. PubMed ID: 36682331 [TBL] [Abstract][Full Text] [Related]
36. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B Dindo M; Oppici E; Dell'Orco D; Montone R; Cellini B J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180 [TBL] [Abstract][Full Text] [Related]
37. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1. Miyata N; Steffen J; Johnson ME; Fargue S; Danpure CJ; Koehler CM Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14406-11. PubMed ID: 25237136 [TBL] [Abstract][Full Text] [Related]
38. The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase. Montioli R; Fargue S; Lewin J; Zamparelli C; Danpure CJ; Borri Voltattorni C; Cellini B Int J Biochem Cell Biol; 2012 Mar; 44(3):536-46. PubMed ID: 22198249 [TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase. Hopper ED; Pittman AM; Fitzgerald MC; Tucker CL J Biol Chem; 2008 Nov; 283(45):30493-502. PubMed ID: 18782763 [TBL] [Abstract][Full Text] [Related]
40. The major allele of the alanine:glyoxylate aminotransferase gene: nine novel mutations and polymorphisms associated with primary hyperoxaluria type 1. Coulter-Mackie MB; Lian Q; Applegarth D; Toone J Mol Genet Metab; 2005; 86(1-2):172-8. PubMed ID: 15963748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]